<?xml version="1.0" encoding="UTF-8"?>
<ref id="B7-pharmaceutics-10-00247" class="ref">
 <label class="label">7.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Rudrangi</surname>
    <given-names class="given-names">S.R.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Kaialy</surname>
    <given-names class="given-names">W.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Ghori</surname>
    <given-names class="given-names">M.U.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Trivedi</surname>
    <given-names class="given-names">V.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Snowden</surname>
    <given-names class="given-names">M.J.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Alexander</surname>
    <given-names class="given-names">B.D.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Solid-state flurbiprofen and methyl-b-cyclodextrin inclusion complexes prepared using a single-step, organic solvent-free supercritical fluid process</article-title>
  <source class="source">Eur. J. Pharm. Biopharm.</source>
  <year class="year">2016</year>
  <volume class="volume">104</volume>
  <fpage class="fpage">164</fpage>
  <lpage class="lpage">170</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1016/j.ejpb.2016.04.024</pub-id>
  <?supplied-pmid 27163245?>
  <pub-id pub-id-type="pmid" class="pub-id">27163245</pub-id>
 </element-citation>
</ref>
